Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Other Non Operating Income (2022 - 2026)

Envoy Medical's Other Non Operating Income history spans 5 years, with the latest figure at $6000.0 for Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 154.55% to $6000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$6000.0, a 72.73% increase, with the full-year FY2025 number at -$23000.0, up 11.54% from a year prior.
  • Other Non Operating Income hit $6000.0 in Q1 2026 for Envoy Medical, up from -$16000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for COCH hit a ceiling of $9.3 million in Q2 2023 and a floor of -$9.4 million in Q1 2023.
  • Historically, Other Non Operating Income has averaged -$425666.7 across 5 years, with a median of -$1000.0 in 2025.
  • Biggest five-year swings in Other Non Operating Income: plummeted 114.16% in 2024 and later surged 154.55% in 2026.
  • Tracing COCH's Other Non Operating Income over 5 years: stood at -$7.0 million in 2022, then skyrocketed by 101.62% to $113000.0 in 2023, then crashed by 114.16% to -$16000.0 in 2024, then changed by 0.0% to -$16000.0 in 2025, then soared by 137.5% to $6000.0 in 2026.
  • Business Quant data shows Other Non Operating Income for COCH at $6000.0 in Q1 2026, -$16000.0 in Q4 2025, and $5000.0 in Q3 2025.